80 related articles for article (PubMed ID: 2425014)
1. Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.
Yamamoto JK; Barré-Sinoussi F; Bolton V; Pedersen NC; Gardner MB
J Interferon Res; 1986 Apr; 6(2):143-52. PubMed ID: 2425014
[TBL] [Abstract][Full Text] [Related]
2. Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4
Itell HL; Humes D; Overbaugh J
Cell Rep; 2023 Jun; 42(6):112556. PubMed ID: 37227817
[TBL] [Abstract][Full Text] [Related]
3. Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4
Itell HL; Humes D; Overbaugh J
bioRxiv; 2023 Feb; ():. PubMed ID: 36798236
[TBL] [Abstract][Full Text] [Related]
4. Human MAIT cells respond to and suppress HIV-1.
Phetsouphanh C; Phalora P; Hackstein CP; Thornhill J; Munier CML; Meyerowitz J; Murray L; VanVuuren C; Goedhals D; Drexhage L; Moore R; Sattentau QJ; Mak JY; Fairlie DP; Fidler S; Kelleher AD; Frater J; Klenerman P
Elife; 2021 Dec; 10():. PubMed ID: 34951583
[TBL] [Abstract][Full Text] [Related]
5. The CD8
Morvan MG; Teque FC; Locher CP; Levy JA
Microbiol Mol Biol Rev; 2021 May; 85(2):. PubMed ID: 33980586
[TBL] [Abstract][Full Text] [Related]
6. Experienced discrimination and racial differences in leukocyte gene expression.
Thames AD; Irwin MR; Breen EC; Cole SW
Psychoneuroendocrinology; 2019 Aug; 106():277-283. PubMed ID: 31029930
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.
Sahay B; Aranyos AM; Mishra M; McAvoy AC; Martin MM; Pu R; Shiomitsu S; Shiomitsu K; Dark MJ; Sanou MP; Roff SR; Rathore MH; Yamamoto JK
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717485
[TBL] [Abstract][Full Text] [Related]
8. Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
Sahay B; Yamamoto JK
Viruses; 2018 May; 10(5):. PubMed ID: 29789450
[TBL] [Abstract][Full Text] [Related]
9. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.
Scagnolari C; Antonelli G
Cytokine Growth Factor Rev; 2018 Apr; 40():19-31. PubMed ID: 29576284
[TBL] [Abstract][Full Text] [Related]
10. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
11. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.
Gupta S; Termini JM; Issac B; Guirado E; Stone GW
PLoS One; 2016; 11(2):e0148929. PubMed ID: 26849062
[TBL] [Abstract][Full Text] [Related]
12. Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines
Katsounas A; Frank AC; Lempicki RA; Polis MA; Asmuth DM; Kottilil S
J AIDS Clin Res; 2015; 6(1):. PubMed ID: 26052470
[TBL] [Abstract][Full Text] [Related]
13. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
Roff SR; Sanou MP; Rathore MH; Levy JA; Yamamoto JK
Hum Vaccin Immunother; 2015; 11(6):1540-56. PubMed ID: 25844718
[TBL] [Abstract][Full Text] [Related]
14. Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.
Graw F; Regoes RR
J Virol; 2014 Sep; 88(17):10134-45. PubMed ID: 24965450
[TBL] [Abstract][Full Text] [Related]
15. Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
Saez-Cirion A; Jacquelin B; Barré-Sinoussi F; Müller-Trutwin M
Philos Trans R Soc Lond B Biol Sci; 2014; 369(1645):20130436. PubMed ID: 24821922
[TBL] [Abstract][Full Text] [Related]
16. The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.
Roff SR; Noon-Song EN; Yamamoto JK
Front Immunol; 2014 Jan; 4():498. PubMed ID: 24454311
[TBL] [Abstract][Full Text] [Related]
17. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
18. Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Fenton-May AE; Dibben O; Emmerich T; Ding H; Pfafferott K; Aasa-Chapman MM; Pellegrino P; Williams I; Cohen MS; Gao F; Shaw GM; Hahn BH; Ochsenbauer C; Kappes JC; Borrow P
Retrovirology; 2013 Dec; 10():146. PubMed ID: 24299076
[TBL] [Abstract][Full Text] [Related]
19. Can non-lytic CD8+ T cells drive HIV-1 escape?
Seich Al Basatena NK; Chatzimichalis K; Graw F; Frost SD; Regoes RR; Asquith B
PLoS Pathog; 2013; 9(11):e1003656. PubMed ID: 24244151
[TBL] [Abstract][Full Text] [Related]
20. Innate immune evasion strategies by human immunodeficiency virus type 1.
Guha D; Ayyavoo V
ISRN AIDS; 2013 Aug; 2013():954806. PubMed ID: 24052891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
